Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05597943 · ClinicalTrials.gov registry record · NA
mHealth Smartphone App and Postpartum Glucose Intolerance for Patients With GDM
A NA study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT05597943 is a NA study that has completed, run by Tufts Medical Center. The registered enrollment target is 30 participants.
The verdict
NCT05597943, a NA study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Without intervention, approximately 70% of women diagnosed with GDM will develop type 2 diabetes mellitus in their lifetime. Abnormal results of a 2 hour oral glucose tolerance test (OGTT) performed as early as 2 days postpartum are predictive of impaired glucose tolerance 1 year postpartum. The investigators hypothesize that use of the Malama smartphone application to optimize antenatal glycemic control will result in lower incidence of postpartum glucose intolerance, which may decrease long term risk of progression to diabetes mellitus.
Interventions
- BEHAVIORAL Malama App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2025-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05597943
The ClinicalTrials.gov registry entry for NCT05597943 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Malama App is the first listed.
NCT05597943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05597943 about?
NCT05597943 is a clinical study titled "mHealth Smartphone App and Postpartum Glucose Intolerance for Patients With GDM". Without intervention, approximately 70% of women diagnosed with GDM will develop type 2 diabetes mellitus in their lifetime. Abnormal results of a 2 hour oral glucose tolerance test (OGTT) performed as early as 2 days postpartum are predictive of impaired glucose tolerance 1 year postpartum. The inv...
What is the current status of trial NCT05597943?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-05-01. Estimated completion is 2025-02-01.
What interventions are being tested in trial NCT05597943?
The interventions under investigation include: Malama App (BEHAVIORAL).
Who is sponsoring clinical trial NCT05597943?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.